The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.


Updates from The Motley Fool

Latest updates on ICON from Fool.com.
Why ICON PLC Stock Soared Today

Shares of the contract research organization soared more than 16% today. Is the move meaningful, ...



Stock Performance

View Interactive ICLR Charts
Sponsored by

Key Data Points

Primary metrics and data points about ICON.
Current Price: $89.44
Prev Close: $90.03
Open: $89.94
Bid: $65.00
Ask: $102.00
Day's Range: $88.88 - $90.67
52wk Range: $63.91 - $90.67
Volume: 267,255
Avg Vol 426,849
Market Cap: $5B
P/E (ttm): 22.68
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ICON.
CAPS Rating 3 out of 5
 
359 Outperform
12 Underperform
CAPS All Stars
 
78 Outperform
4 Underperform

How do you think ICON will perform against the market?



You pick for ICON is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ciaran Murray, CEO

66% Approve

Based on 178 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ICON.

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT